Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04272645
Title Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Indications

prostate adenocarcinoma

Therapies

Abemaciclib + Atezolizumab

Abemaciclib

Atezolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST